EurekAlert!: Updates in chronic subdural hematoma: from epidemiology, pathogenesis, and diagnosis to treatment Updates in chronic subdural hematoma: from epidemiology, pathogenesis, and diagnosis to treatment PHOENIX, AZ—Middle meningeal artery (MMA) embolization with liquid agents looks set to become the standard of care for the treatment of nonacute subdural hematoma after three randomized trials ... Patients receiving standard treatment for chronic subdural hematoma have a high risk of treatment failure. The effect of adjunctive middle meningeal artery embolization on the risk of treatment ...

Understanding the Context

A novel combination of surgery and embolization used to treat subdural hematomas, bleeding between the brain and its protective membrane due to trauma, reduces the risk of follow-up surgeries, ... The New England Journal of Medicine: Dexamethasone versus Surgery for Chronic Subdural Hematoma In this multicenter, open-label, controlled, noninferiority trial, we randomly assigned symptomatic patients with chronic subdural hematoma in a 1:1 ratio to a 19-day tapering course of dexamethasone ... Chronic subdural hematoma (CSDH) is one of the most common neurosurgical conditions, particularly among the elderly, with an annual incidence ranging from 1.7 to 20.6 per 100,000 people. As the global ...

Key Insights